[PDF] Top 20 Insulinoma, presentación y evolución de dos casos clínicos
Has 10000 "Insulinoma, presentación y evolución de dos casos clínicos" found on our website. Below are the top 20 most common "Insulinoma, presentación y evolución de dos casos clínicos".
Bupropion in the treatment of major depressive disorder: a comparison with paroxetine
... jor Depressive Disorder (MDD), were recruited among patients followed at the outpatient psychiatric facility at Policlinico Universitario, Catania, Sic- ily, Italy, to compare the efficacy and tolerability ... See full document
22
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
... PAX treatment, multi- logistic regression analysis was ...For comparison of the discontinuation rates between MDD patients and PD patients, the chi-square test or the Fisher’s exact test (when data were ... See full document
6
Duloxetine in the treatment of major depressive disorder: an open label study
... assess treatment-emergent impairment of sexual ...of comparison, in four double- blind, placebo- and paroxetine-controlled studies of up to 9 months duration, the Arizona Sexual Experience (ASEX) ... See full document
15
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
... the treatment groups by an independent t-test and a chi-square test, ...The comparison between the escitalopram and paroxetine controlled-release treatment groups was made by determining the ... See full document
55
Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
... CR paroxetine after IR paroxetine with continuous use of IR ...IR paroxetine use (the mean HSDS score was ...a comparison of the included and excluded patients by comparing the results of the ... See full document
7
Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
... All 8 studies included in these analyses were randomized, multicenter, double-blind, placebo-controlled clinical tri- als and represented all of the double-blind studies included in the New Drug Application reviewed by ... See full document
12
The Association of Antidepressant Medication and Body Weight Gain
... with major depressive disorder, the efficacy of mirtazapine was compared to ...Another comparison was made between the efficacy and tolerability of mirtazapine versus paroxetine in 275 ... See full document
11
Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized–controlled trials comparison with venlafaxine
... that bupropion is less likely to cause treatment-emergent sexual ...of bupropion in the treatment of MDD compared with other antidepressants, including SSRIs, may be ... See full document
12
COMPARISON OF EFFICACY OF EXTENDED RELEASE VENLAFAXINE VERSUS SERTRALINE IN TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER
... Bauer and colleagues [22] reported higher efficacy for venlafaxine compared with SSRI but discontinuation rate for side effects was alike. Bu the rates of side effects and efficacy were alike between two groups in our ... See full document
10
Comparative efficacy and safety of <em>Crocus sativus</em> L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials
... and comparison medications, dosage and duration of interven- tion, outcome measures, baseline data, post-treatment data or change from baseline, number of dropouts for all reasons, and adverse ... See full document
14
An attempt to construct a 7 item short version of the temperament and character inventory to predict the treatment response of patients with depression; a validation study
... the treatment response of patients with major depressive disorder ...of paroxetine for six weeks, and then the participants completed the ...the treatment response in the ... See full document
35
Continuation treatment of major depressive disorder: is there a case for duloxetine?
... and paroxetine were superior to placebo (P ...of treatment loss of response was defined as the first visit at which the HAM-D showed a less than 30% reduction from the acute baseline ...for ... See full document
7
Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
... This post-hoc analysis is based on data obtained from a 24-week prospective, observational study which was primarily aimed at examining treatment-emergent sexual dysfunction (TESD) and other clinical outcomes in ... See full document
5
Comparative efficacy of escitalopram in the treatment of major depressive disorder
... meta-analysis that included 117 randomized controlled trials (with 19 escitalopram trials) from 1991 to November 2007, including 15 unpublished trials obtained from pharmaceuti- cal company websites. The primary ... See full document
9
Antidepressant medication treatment patterns in Asian patients with major depressive disorder
... Comparison of the baseline demographics and clinical characteristics of the patients who were followed (ie, with both baseline and endpoint assessment, n = 430, 75.6%) and those lost to follow-up (ie, with ... See full document
16
Interpersonal psychotherapy in the treatment of major depressive disorder: a review
... for comparison among differ- ent types of brief psychotherapy, IPT is one of the most widely used therapies for major depression and showed an efficacy equivalent to cognitive-behav- iour ...with ... See full document
13
Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
... of major depression (Diag nostic and Statistical Manual of Mental Disorders [DSM-IV] criteria) of at least 3 months’ duration without any history of treatment ...direct comparison trial of ... See full document
38
Complementary and alternative medicine for the treatment of major depressive disorder
... There is insufficient evidence to recommend folate for the treatment of depression. Because folate deficiency is associated with poorer outcomes in depression, as well as mild cognitive impairment, megaloblastic ... See full document
88
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
... traits, major depressive disorder, suicide attempts, and bipolar ...hyperactivity disorder. For some disorders, such as post-traumatic stress disorder and major depressive ... See full document
12
Phenobarbital Treatment and Major Depressive Disorder in Children With Epilepsy
... Although there was a nonsignificant tend- ency to treat patients with partial complex seizures with carbamazepine and to treat patients with gen- eralized seizures with phenobarbital, th[r] ... See full document
14
Related subjects